Yeungnam University College Of Medicine

This study is testing a personalized treatment schedule for a drug called faricimab, which is injected into the eye. It aims to control a serious eye disease called polypoidal choroidal vasculopathy (PCV), which can cause vision loss. The main goal is to see if patients can safel…

This study is testing a personalized, high-dose version of an existing eye injection (aflibercept 8mg) for people with a specific eye condition called polypoidal choroidal vasculopathy (PCV). The goal is to see if this stronger dose, given on a flexible schedule, can effectively …